Alzamend Neuro, Inc.
USD1.15
+0.01 (+0.88%)
CEO
Stephan Jackman
IPO Date
2021-06-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.13
Prev. Close
$1.14
Day Low
$1.11
Day High
$1.16
52W Low
$0.84
52W High
$4.00
Market Cap
$0.00B
Volume
0.03M
| 1,851 |
| $2.07 |
| 23 Dec 2025 | Horne William B. | director | S-Sale | Disposed | 3,333 | $2.12 |
| 24 Oct 2025 | McGrath Lynne Fahey | director | S-Sale | Disposed | 30 | $2.29 |
| 10 Oct 2025 | AULT MILTON C III | director | C-Conversion | Acquired | 61,743 | $2.32 |
| 10 Oct 2025 | AULT MILTON C III | director | S-Sale | Disposed | 101,394 | $2.44 |
| 10 Oct 2025 | AULT MILTON C III | director | S-Sale | Disposed | 20,397 | $2.32 |
| 10 Oct 2025 | AULT MILTON C III | director | C-Conversion | Disposed | 143.245 | $2.32 |
| 8 Oct 2025 | AULT MILTON C III | director | C-Conversion | Acquired | 100,000 | $2.32 |
| 8 Oct 2025 | AULT MILTON C III | director | S-Sale | Disposed | 82,033 | $2.45 |